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Purpose: Quantitative ultrasound bone sonometry (QUS) might be a promising screening method for cystic ﬁbrosis (CF)-related bone disease, giv-
en its absence of radiation exposure, portability of the equipment and low cost.The value of axial transmission forearm QUS in detecting osteo-
penia in CF was therefore studied.
Methods: We investigated the application of QUS in the evaluation of bone status in a group of 64 adolescents (>12 years) and young adults
(b40 years) with CF in a comparison with a dual X-ray absorptiometry (DXA) of the whole body and peripheral quantitative computed tomogra-
phy (pQCT) of the radius at 4% and 66% sites.
Results: Mean (SD) Z-scores of speed of sound (SOS), whole body bone mineral content (BMC), radial trabecular bone mineral density (BMD),
and radial cortical BMD were respectively −0.31 (0.78), −0.09 (1.28), 0.10 (1.16) and −0.62 (2.88). The pQCT determined bone geometry values
(cortical bone area and cortical thickness) were more depressed than the BMD data. QUS had a sensitivity and speciﬁcity of respectively 0% and
96% for diagnosing osteopenia (based on a whole body BMC Z-scoreb−2).
Conclusions: QUS cannot replace DXA, but can screen out patients with normal bone mass. Further and larger studies are needed to examine if
QUS may reﬂect other aspects than bone mass, or if it is possible to improve its sensitivity by supplementing the SOS results with clinical risk
factors.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Bone mass; Bone densitometry; Osteoporosis; Quantitative ultrasound bone sonometry1. Introduction
In adolescents and adults with cystic fibrosis (CF) the high inci-
dence of osteopenic bone disease, called CF-related bone disease,⁎ Corresponding author at: UZ Brussel, Laarbeeklaan, 101, 1090 Brussels,
Belgium. Tel.: +32 2 477 5767; fax: +32 2 477 57 83.
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doi:10.1016/j.jcf.2011.10.004requires monitoring of the skeletal status. [1,2]. The recommenda-
tion for regular DXA examinations in CF patients can be ques-
tioned since no correlation between DXA and vertebral and/or
rib fractures has been observed in cross-sectional studies [3,4].
Furthermore, the interpretation of DXA results, especially in ado-
lescents, is complicated by a frequent delay in pubertal growth
and development and the lack of adjusted volumetric bone mineral
density (BMD) results by most commercial densitometers.by Elsevier B.V. All rights reserved.
120 J. De Schepper et al. / Journal of Cystic Fibrosis 11 (2012) 119–124Although still not a widespread available technique, periph-
eral quantitative computed tomography (pQCT) not only offers
the advantage of measurements of dyspneic patients in a sitting
position, but also provides results on bone geometry and gives
real volumetric BMD results of separate cortical and trabecular
bone measurements at the radius or tibia. Longitudinal DXA
and pQCT data are scarce in this population and the policy of
regular bone status monitoring with these techniques will result
in unwanted additive radiation doses in CF patients, although
the effective doses of these bone examinations are among the
lowest of doses resulting from commonly used medical X-ray
examinations and lower than a standard chest X-ray [5]. An al-
ternative might be the use of quantitative ultrasound bone sono-
metry (QUS), which gives more assessment of the bone quality
than bone quantity [6]. The axial transmission ultrasound tech-
nique allows the measurement of the sound progression, la-
beled as the speed of sound (SOS), at several peripheral bone
sites. QUS has particular advantages for monitoring of CF relat-
ed bone disease, since it is a non radiating and easy to use tech-
nique, allowing bed-side monitoring without positioning
problems, especially when the axial transmission mode is
used. We therefore investigated the application of forearm
axial transmission QUS in the evaluation of bone status in a
group of adolescents and young adults with CF.
2. Methods
All adolescent (>12 years of age) and young adult
(b40 years of age) CF patients who attended the Cystic Fibrosis
Clinics of the Brussels University hospital (Universitair Zieken-
huis Brussel, Brussels, Belgium) and of the Ghent University
hospital (Universitair Ziekenhuis Gent, Ghent, Belgium) were
considered for this study, after informed consent. Exclusion cri-
teria were the use of any bone active medication, with the ex-
ception of corticoids or routine vitamin D supplementation,
being on a waiting list for lung transplantation or already hav-
ing received a lung transplant. Of the 68 CF eligible individ-
uals, 58 attending the Universitair Ziekenhuis Brussel for
their annual screening for complications between mid 2006
and mid 2007, agreed to participate. At the Universitair Zieken-
huis Gent, recruitment was only done during the last 5 months
of the study inclusion period due to logistic problems. In total
21 of the 35 eligible patients, who had been programmed for
their annual check-up, only 16 patients had complete bone
data available for analysis. The Institutional Ethical Review
Boards at both University hospitals approved the study.
In both hospitals bone assessment was performed with the
same devices. All DXA scans were performed with a Hologic
QDR 4500A densitometer (Hologic Inc., Bedford, MA,
USA). Whole body measurements were performed in a stan-
dardized way and analyzed using the same software (version
V8.24a:3). DXA measurement of the whole body was chosen
since it allows the determination of the body composition,
which is of major importance in the nutritional monitoring of
CF patients. Bone mass (BMC) measurements are given as g
(hydroxy-apatite) and Z-scores using the normative data of
Sala et al. [7]. BMD measurements are reported in g/cm2 andZ-scores, as delivered by the apparatus. The coefficient of var-
iation (CV) % isb3% for BMC data andb1% for BMD data.
QUS measurements were done with an Omnisense 7000P appa-
ratus (Sunlight Ltd, Tel Aviv, Israel) at the distal left radius as
described by the manufacturer. SOS measurements were
reported in m/s and Z scores (age and gender adjusted standard
deviation scores), as delivered by the incorporated software.
The CV % with repositioning isb2% for the SOS result. A
2000 Stratec pQCT device (Stratec Medizintechnik, Pforzheim,
Germany) was used to perform measurements at the left radius
at the distal (4% of fore-arm length) and the proximal (66%)
site. Total BMD at the proximal site and trabecular BMD at
the distal site were analyzed using the same software version
(version 6.00). In addition, at the proximal site total bone
cross-sectional bone area and cortical cross-sectional bone
area and cortical wall thickness were assessed at the proximal
site. Z-scores of the bone mineral density data assessed at the
distal site, as calculated by the software of the pQCT device,
were used. The Z-scores of the variables measured at the prox-
imal site were calculated with the regression equations devel-
oped by Neu et al. [8]. The CV % is 3% for bone geometry
data andb2% for BMD data.
At moment of bone analysis, standard anthropometry and
spirometry, as well as a liver ultrasound scan were performed.
The ultrasound scoring system of Williams et al. was used to al-
locate patients to a no liver disease group (scoreb4), a moder-
ate liver disease (score 4–8) and severe liver disease (with
portal hypertension) (score>8) [9]. In all but one patient verte-
bral bone deformities were analyzed at an X-ray of the chest
obtained within 6 months of the bone analysis by the semi-
quantitative method described by Genant et al. [10].
Statistical analysis was performed using the SPSS (SPSS,
Chicago, IL) software program. The results for continuous
data are given as mean±SD and for non-continuous variables
are represented as a frequency and a percentage. Comparisons
were made by T-tests or ANOVA. Univariate and multivariate
statistical tests were applied to explore for associations between
the bone measurements.
3. Results
3.1. Clinical data
Table 1 represents the clinical data of the studied population at
study enrollment. The study group included 35 males and 29 fe-
males with a median (range) age of 20 (12–38) years. Twenty
seven patients were younger than 18 years. As shown in Table 1,
females had a significantly lower mean relative body height,
body mass index (BMI) and Forced Expiratory Volume in the
first second (FEV1) values. In total 13 (20%) patients were suffer-
ing from severe respiratory insufficiency (FEV1b50%) and
4 (6%) were undernourished (BMI Z-scoreb−2). Fourteen
(21%) patients were treated for CF-associated diabetes mellitus.
The majority of patients (41 in total or 64%) had a normal liver ul-
trasound scan, while severe liver disease was documented in
9 (14%) subjects. Oral corticoids had been taken for at least during
3 months in the preceding year by 6 patients. None of the adult
Table 1
Mean (SD) clinical characteristics in female and male CF patients.
Clinical variables Females (n=25) Males (n=39 ) All (n=64)
Age (years) 20.8 (6.4) 20.5 (5.7) 20.6 (5.9)
Height (cm) 161.7 (6.6) 171.2 (9.8)** 168.0 (9.8)
Height (sds) −0.58 (1.08) 1.09 (1.27)** 0.44 (1.5)
BMI (kg/m²) 19.8 (2.5) 20.0 (2.2) 19.9 (2.3)
BMI (sds) −0.47 (0.88) −0.37 (0.89)* −0.41 (0.89)
FEV1 (% predicted) 62.6 (22.5) 79.1 (22.9)* 72.7 (24.0)
Liver disease
(Abs/Mod/Sev) a
15/6/4 26/8/5 41/14/9
Diabetes (yes/no) 9/16 5/34 14/50
Corticoids (yes/no) 1/24 5/34 6/58
*pb0.005 between females and males; **pb0.0001 between females and
males.
a Abs=absent; Mod=moderate; Sev=severe.
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berty. Vertebral deformities were observed in 36 (21 males and
15 females) of the 68 studied patients.3.2. Comparison of the bone data
The results of bone analysis (as a group and by gender) are
shown in Table 2. No gender difference in radial SOS Z-scores
was present. Females had significantly higher age-adjusted
whole body BMC values by DXA than males, but lower radial
distal trabecular BMD values and radial proximal bone areas
(assessed by pQCT). Of all studied bone parameters, the lowest
Z-scores were obtained in females for the cortical thickness re-
sults, while in males the lowest bone values were observed for
the radial total BMD determinations (Fig. 2). No significant dif-
ference in the DXA, pQCT and QUS results was found between
patients with or without vertebral fractures (data not shown).Table 2
Mean (SD) bone measurements results in female and male CF patients.
Bone measurements Females (n=25)
SOS (m/s) 4003 (139)
SOS (sds) −0.47 (0.88)
Whole body BMC (g) 1885 (267)
Whole body BMC (sds) 0.80 (0.77)
Whole body BMD (g/cm²) 1.08 (0.08)
Whole body BMD (sds) 0.14 (0.93)
Distal radial trabecular BMD (g/cm³) 174 (41)
Distal radial trabecular BMD (sds) −0.44 (1.26)
Proximal radial total BMD (g/cm³) 675 (105)
Proximal radial total BMD (sds) 0.69 (1.21)
Proximal radial cortical BMD (g/cm³) 1063 (120)
Proximal radial cortical BMD (sds) −0.22 (2.72)
Proximal radial total area (mm²) 125 (23)
Proximal radial total area (sds) −0.39 (1.91)
Proximal radial cortical area (mm²) 61 (8)
Proximal radial cortical area (sds) −1.18 (0.88)
Proximal radial cortical thickness (cm) 1.82 (0.26)
Proximal radial cortical thickness (sds) −1.87 (0.66)
*pb0.005 between females and males; **pb0.0001 between females and males.Overall, as a group, CF patients had significantly (pb0.005)
decreased SOS Z-scores. A radial SOS Z-score below −2 was
found in only 2 patients (Fig. 1). DXA detected respectively 6
and 1 patient with a whole body BMC and BMD Z-score
below −2. Abnormal low (Z-score below −2) radial trabecular
and cortical BMD results were seen respectively in 2 and 12
subjects, but severely decreased (Z score below −2) cross-
sectional total bone area and cortical thickness values were ob-
served in respectively 27 and 14 patients. Using the whole body
BMC Z-score below −2 to diagnose low bone mass or osteopo-
rosis and calculating with a cut-off Z-score of SOS ofb−2, a
sensitivity of 0% and a specificity of 96% were found. Positive
and negative predictive values of QUS were respectively 0%
and 90% in detecting osteoporosis.
3.3. Parameters influencing bone data
No significant correlation coefficients between the SOS Z-
scores and the Z-scores of all the studied bone parameters were
found. Absolute SOS results correlated significantly (pb0.05)
with radial cortical BMD as assessed by pQCT, both in females
(r=0.58) and males (p=0.36) as well as with whole body BMC
in females (r=0.44) and males (r=0.39), but after correction for
age, the significance of the observed correlations disappeared.
Using linear regression analysis, SOS Z-scores were found to
be independent of age and age-adjusted anthropometric data.
BMI Z-score correlated positively with cortical area Z-score
(r=0.37; pb0.05) and whole body BMD Z-score (r=0.32;
pb0.05) in males, but no significant correlation was found in
the females. On the other hand only in the female group, age cor-
related significantly negatively and FEV1 correlated positively
(r=0.47; pb0.05) with cortical bone thickness Z-scores (r=
−0.55; pb0.005). Patients who had received oral corticoids dur-
ing the past year had also similar age and gender adjusted bone
parameters compared to those without corticoid therapy. TheMales (n=39) All (n=64)
3935 (126) 3961 (134)
−0.37 (0.89) −0.31 (0.78)
2353 (484)** 2170 (471)
−0.66 (1.2)* −0.09 (1.28)
1.19 (0.13)** 1.14 (0.13)
0.65 (1.17) 0.47 (1.32)
236 (36)** 212 (49)
0.44 (0.96)* 0.10 (1.16)
705 (128) 693 (120)
0.31 (1.39) 0.46 (1.33)
1034 (124) 1045 (122)
−0.88 (2.92) −0.62 (2.88)
150 (26)* 140 (34)
−2.65 (1.88)** −1.77 (2.18)
80 (17)** 72 (17)
0.87 (1.58)** 0.06 (1.68)
1.82 (0.14)** 1.9 (0.26)
−1.1 (0.76)** −1.4 (0.81)
Fig. 1. Scattergraph of SOS Z-score in relation to whole body BMC Z-score in CF males and females.
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ments (ANOVA analysis). Diabetic patients (n=14) had signifi-
cantly (pb0.05) lower Z-scores for proximal radial cortical areaFig. 2. Box plot of Z-scores of the different b(pb0.05), cortical thickness (pb0.005), distal trabecular and
total BMD (pb0.05) measurements in comparison with non-
diabetic patients.one parameters in CF males and females.
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The major aim of this study was to evaluate if QUS could be
used as a selective population pre-screen method, in order to
maximize the cost effectiveness of referral for DXA examina-
tions and to limit at the same time the radiation dose to CF pa-
tients. The observed relatively high negative predictive values
in our study suggest that QUS may reliably screen out patients
unlikely to have a decreased bone mass by DXA. The absent
positive predictive power, however, means that subjects classi-
fied as having a low QUS result should have further investiga-
tions to confirm the diagnosis of low bone mass. Since QUS
and densitometric methodologies do not measure identical
properties of bone tissue, it could be expected that these tech-
niques would not capture the same patients. In 2001, for the
first time bone quality was investigated by quantitative ultra-
sound (QUS) at the calcaneus in a cross-sectional sample of
29 CF children between 5 and 16 years of age. In this study
QUS results were not different form an age and height matched
healthy control group. Although whole body BMC and BMD
was measured by DXA, no predictive values were calculated
[11]. In a subsequent larger study of 75 adult patients with
CF, QUS at the calcaneus had a sensitivity and a specificity
of only 57% and 89% respectively for diagnosing osteoporosis,
which was based in this study on a femoral neck T scoreb−2.5
by DEXA [12]. In our study, whole body bone mass was stud-
ied and in accordance with the most recent recommendations,
Z-scores were used to define the degree of demineralization,
since adolescents and young (b40 years) CF adults were stud-
ied and the majority of patients have not yet reached their
peak bone mass [1,13]. Our finding of a low to absent sensitiv-
ity of QUS does not mean that sonometry has no place at all in
evaluating the bone status in CF. Only prospective comparison
of these three techniques to predict fractures on the long-term
may clarify the future clinical utility of any of these methods
in CF patients [14,15]. Up to now, only one study has evaluated
both QUS and DXA in vertebral bone fracture prediction in CF
patients: phalangeal QUS as opposed to calcaneal QUS and
DXA was found to discriminate between adult patients with
and without vertebral fractures [4]. In our study, radial QUS
was not able to discriminate CF adolescent and young adult
CF patients with prevalent vertebral deformities from non-
fractured patients.
We found that the majority of CF adolescents and young
adults had a normal bone mineral status when examined by
DXA, pQCT or QUS. The current study was performed in ad-
olescents and young adults, who benefitted from the most re-
cent therapeutic interventions, with exclusion of patients listed
for transplantation, explaining the rather limited degree of
lung disease and malnutrition. In most previous studies both
the younger and the healthier CF individuals were found to
have a normal bone mineralization. In patients with severe
lung disease (FEV1b30%), who are referred for lung trans-
plant, the most severe CF related bone disease is found [16].
Whereas bone mineral data were within normal limits in most
of patients in our study, a significant number were at risk for
small radial bone sizes. Especially older and less healthy femaleCF patients were found to be at risk for thin forearm bones. In
clinically stable osteopenic adults, bone area, bone formation
rate and wall width in bone biopsies were found to decrease
up to 50% [17]. The finding of rather small bone size in CF pa-
tients is an important issue, since the disturbed radial bone
growth will lead to an overdiagnosis of osteoporosis when
using DXA for defining osteopenia or osteoporosis.
In our study, for the first time a comparison between SOS
and pQCT results has been made in CF patients: absolute
SOS results were found to correlate with radial cortical BMD
values. An earlier study with the same QUS apparatus found
that in healthy young adolescents tibial SOS results (the radius
site was not investigated in this study) correlated with cortical
BMD measured at the same bone site [18]. Another important
finding in our comparative study was that in general bone ge-
ometry values were found to be more depressed than bone den-
sity data. We further evaluated if the degree of bone mineral
quantity and quality impairment were related to known condi-
tions of increased bone fragility. CF related diabetes mellitus
was found to particular influence both bone size and trabecular
BMD in our group of rather well nourished patients. Surpris-
ingly, the influence of diabetes on the bone mineral content
has not been well studied in CF patients up to now, despite
the fact that more than 50 studies have investigated the clinical
correlates of CF bone disease in the past 20 years. However, in
a recent Israeli study investigating the consequences of CF re-
lated diabetes in adults, a lower BMD at the lumbar spine and
femur was evidenced by DXA [19].
There are several limitations to our study. We had a limited
number of severely attained patients and only very few had
bone abnormalities assessed by QUS, limiting the possibility
of detecting severe bone disease. There is however a consensus
that it is mandatory to identify CF related bone disease early in
its course to allow earlier therapeutic interventions to optimize
bone health. Another weakness is the absence of any anamnes-
tic assessment of fractures, although the accuracy of this kind of
information is in general poor.
In conclusion, radial QUS identified bone abnormalities in
less than 5% of rather well-nourished CF patients in our com-
parative bone study. The SOS was not influenced by the sever-
ity of the lung and liver disease and QUS results were
independent of anthropometric data. QUS cannot replace
DXA in evaluating whole body bone mass in CF adolescents
and young adults, but it can screen out patients with a normal
bone mass.Conﬂict of interest
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